• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Bal Pharma Limited — Board Meeting, 12-11-2025: Outcome of Board Meeting

    12-11-2025 | 06:24 pm

    Bal Pharma's board approved Q2 & H1 consolidated financial results. Q2 revenue stood at ₹74.02 Cr, with profit at ₹0.72 Cr. H1 revenue was ₹139.90 Cr, delivering ₹0.93 Cr profit. Dr. Bheekamchand Mukesh was appointed as an Additional Independent Director.

    No comments yet. Be the first to comment!

    All announcements from Bal Pharma Limited